YOUR VOICE DESERVES TO BE HEARD

At Global Patients, we invite you to take part in telephone interviews, focus groups and online surveys. Our studies ask you to share your experiences with your condition and treatment, so our scientists can learn how to improve the quality of life of patients in the future. We know your time is valuable and your feedback is invaluable to us. For this reason, we compensate you well for your time for every study that you take part in. Sign up to be one of our Global Patients today. If you have any questions about how we work, please check our FAQs section or get in touch with one of our Patient Supporters.

FAQs JOIN OUR GLOBAL PATIENTS

If you already are one of our Global Patients or want to check out what we are up to, take a look at our current studies!

FIND A STUDY

FREQUENTLY ASKED QUESTIONS

Do you have a question?
We have an answer!

How do I subscribe to Global Patients?

You can join us by clicking Here. Easy and fast!

How do I unsubscribe?

If you would like to unsubscribe, please send us an email to contact@global-patients.com and we will immediately delete your data from our database.

What happens on a typical study?

Once you are interested in a study, we will kindly ask you some questions online in order to check whether you are eligible. If so, we will schedule a call with you in order ask you some screening questions to verify if your profile is eligible for that specific study and if it is you would be invited to participate. If you are not, no worries! We have many studies running worldwide with different criteria.

How do I get paid?

We will send you a virtual Visa card or Mastercard after the completion of the study. Your reward will be delivered to your email address by our rewards partner

How much money can I expect?

We always pay a fair compensation, around $100 (75 GBP, 80 EUR) for an hour of your time.

Still not sure?

If your question is not in this list or you want to get to know us better, talk with one of our patient supporters We would love to meet you!

OUR PATIENT SUPPORTERS

We are here to support you and make sure you have a great experience as a Global Patient.
Click here to contact us and we will be happy to help you!

JOANNA Joanna

Joanna has an adventurous personality, and has lived in Belgium, Spain and the USA. She loves martial arts and spending quality time with her family and friends. Besides this, she hates cooking but she loves indie music and vintage clothing.

Fun fact: Joanna is a bit obsessed with Italy, she has been there many times, speaks Italian and even got married in Rome.

REBECA Rebeca

Rebeca has lived in the UK. She loves reading and spending time with her family and friends as well as travelling. Besides this, she is always up for a good plan that involves spending time outdoors!

Fun fact: Rebeca loves cooking, but she would rather go out to a nice restaurant and enjoy a night out.

NOELIA Noelia

Noelia lived and worked in the UK for six years. She loves good music, travelling and getting to know new cultures and foreign languages.

Fun fact: Noelia is a big fan of escape rooms!

MONICA Monica

Mónica has a gentle and enthusiastic personality. She studied in the US and loves to be constantly learning. She has travelled to many countries and likes to keep in touch with friends from all over the world.

Fun fact: Enjoys international cuisine and loves jazz music.

MIRYAM Miryam

Miryam lived and worked in Vancouver, Canada. She loves cinema and reading. She enjoys traveling and visiting new places. She likes trying new dishes from around the world and meeting new people.

Fun fact: Miryam sings all the time at home when she is with her family.

MIRIAM Miriam

Miriam lived in London for over 10 years and is an English literature lover. She has an easy-going personality and enjoys classic cinema, 80s british music and travelling.

Fun fact: Miriam loves animals and is mad about dogs, especially about her dachshund Pompeya

JUDIT Judit

Judit lived and worked in Italy, Switzerland, Hungary and the USA.Her main passion are sports and healthy living as she was a former professional water polo player.She also loves nature, animals, travelling and getting to know more and more about our beautiful world.

Fun fact: Judit loves going hiking!

VERONICA Verónica

Veronica has lived in the UK. She loves exploring new places and meeting people from different cultures. She loves to travel with friends and living new experiences.

Fun fact: She is a speed lover and really enjoys motorbike routes!

LEYRE Leyre

Leyre has lived in Germany. She loves reading and cooking. Besides this, she is always up for visiting new places and getting to know people from different backgrounds.

Fun fact: Leyre never says no to a good outdoors plan!

SHANE Shane

Shane has lived and worked in Ireland and Spain for many years and taught people to drive a range of road and work vehicles. He loves playing music and climbing mountains in his spare time.

Fun fact: Shane is a collector of musical instruments!

BELEN Belén

Belen has lived in England, New Zealand and China. Her hobbies are travelling and reading. Belen also does yoga and she loves eating exotic food. Since she moved to Asturias Belen loves hiking and exploring new corners of the region.

Fun fact: Belen´s dream is to have a house in the countryside with a kitchen garden and fruit trees!

FIND A STUDY

These are the projects we currently have in field.
Do not hesitate to contact us if you are interested in having more info!

GP0016B Dry AMD in the US

At Global Patients we are launching a study in relation to Dry AMD.  The purpose of this study is to learn more about the experiences of patients living with Dry AMD and/or their caregivers, and how it affects their lives on a day-to-day basis. Have you or a loved one been diagnosed with dry age-related macular degeneration (AMD)?  We are looking for people aged 50 or older with AMD and/or

GP0511D – Head and Neck Cancer in the US

At Global Patients we currently have a study in the US with patients who have Locally Advanced or Metastatic Head and Neck Cancer. The study will consist of two 60-minute-long interview. We appreciate the time participants invest in our interviews, and that’s why we offer an incentive of 200 USD as a token of appreciation. If you are interested or know anyone who would be, please do not hesitate to

GP0937C Desmoid Tumor

At Global Patients we are launching a new study in the US to learn more about the experiences of people with desmoid tumors.
The study will consist of a 45-minute web-assisted interview. For those who complete the interview, we offer an incentive of $75 as a token of appreciation for your time. If you want ta participate please, contact us at miryam@global-patients.com
We look forward to hearing from you!

GP0917D Multiple Sclerosis (MS) treatment study in the UK

At Global Patients we are launching a new study where we want to learn more about Multiple Sclerosis and its treatments in the UK. This study aims to understand more about patients’ experience living with Relapsing-Remitting Multiple Sclerosis (RRMS). We are interested in speaking to people who meet the following criteria: Have been diagnosed with RRMS Are currently receiving a disease-modifying treatment for their MS Have made a treatment decision

GP0905D AHDS-MCT8  en España

En Global Patients estamos llevando a cabo una investigación cualitativa por encargo de una empresa farmacéutica y nos gustaría conocer su opinión. Buscamos cuidadores de pacientes con deficiencia de MCT8 o síndrome de Allan-Herndon-Dudley,  para que participen en un estudio para explorar y comprender su experiencia y recoger sus opiniones. Los participantes completarán una tarea previa de 60 minutos y una entrevista telefónica de 90 minutos. Para agradecerle su tiempo,

AHDS-MCT8 deficiency caregivers in the US and UK 

At Global Patients we are conducting qualitative research on behalf of a pharmaceutical company and would truly value your opinion. We are looking for caregivers of a MCT8 deficiency patient to participate in a study to explore and understand how they experience a specific medical condition. If you are eligible and interested to participate, we will guide you in the pre-tasks collection and we will arrange a 1 hour and

GP0196E Recurrent Kidney Stone Formers in the UK

We are launching a new study, where we want to learn more about the experiences of Kidney Stone patients. The research will take the form of a 60 min interview.
In appreciation of your time, each participant will receive £80 upon completion of the study.
If you or someone you know meets these criteria and would like to participate, please feel free to contact us at judit@global-patients.com

GP0811D AML patients in US and UK

We are launching a new study and want to hear from people with a diagnosis of Acute Myeloid Leukemia (AML). This study is being conducted to understand more about patients experiences with their treatment for AML in the US and UK. As well as showing some information about potential new treatments for AML, to understand perceptions of these.  The research is not intended to be promotional in any way. The

GP0783D BP pacientes y cuidadores

Estamos realizando un estudio sobre el penfigoide ampolloso, o PA, en España en nombre de una empresa farmacéutica promotora. El estudio consiste en una única entrevista telefónica de 60 minutos. Para agradecer su tiempo, le compensaremos con €35 por la entrevista, más €15 por compartir un documento que confirme su diagnóstico de PA. Ambos pagos se realizarán en forma de vale de regalo electrónico. Si tiene un/a cuidador/a al/a la

GP0783D BP patients and caregivers

We are conducting a study in bullous pemphigoid, or BP, in the United States on behalf of a pharmaceutical company sponsor. The study consists of a single 60-minute phone interview. To show our appreciation for your time, you will be compensated $125 for the interview, plus $25 for sharing a document that confirms your diagnosis of BP. Both payments will come in the form of an electronic gift card voucher.

GP0883B Mieloma múltiple quiescente

Evidera, una empresa de consultoría en el ámbito de investigación en salud, le invita a participar en una entrevista telefónica/online sobre su experiencia con el mieloma múltiple quiescente (y el mieloma múltiple, cuando sea aplicable). Como parte de esta entrevista, le pediremos que complete unos formularios online a través de un enlace que le enviaremos por correo electrónico. La entrevista tendrá una duración de unos 60 minutos. Para agradecerle su

GP4800 Cáncer de Próstata

Hemos lanzado un nuevo estudio en Global Patients para obtener más información sobre la experiencia de pacientes adultos diagnosticados con cáncer de próstata en España. El estudio consiste en participar en una encuesta online y por la que los participantes recibirán un incentivo de 50€ como muestra de agradecimiento por su tiempo. Si usted o alguien que conoce cumple con estos criterios y desea participar, por favor, póngase en contacto

GP0955D Eosinophilic Gastritis (EG) and Eosinophilic Gastroenteritis (EGE) patients in US

We are conducting a study in Eosinophilic Gastritis (EG) or Eosinophilic Gastritis with Eosinophilic Gastroenteritis (EG+EGE) on behalf of a pharmaceutical company sponsor. The study consists of a single 60-minute phone interview. We are looking to interview adolescents (12-17 years old) and adults that have either condition. To show our appreciation for your time, you will be compensated $125 for the interview, plus $50 for sharing a document that confirms

GP0045E Bullous Pemphigoid patients in the US

We are launching a new study, where we want to learn more about the experiences of Bullous Pemphigoid patients. The research will take the form of a 75 min interview. In appreciation of your time, each participant will receive $200 upon completion of the study. If you or someone you know meets these criteria and would like to participate, please feel free to contact me at judit@global-patients.com I look forward

GP0182B – Non-Hodgkin Lymphoma in Spain

We have launched the following study in Spain. Please see specifications below: Global Perspectives está trabajando con Evidera, una empresa de investigación científica, para conocer las opiniones de los pacientes sobre el linfoma (un tipo de cáncer de la sangre). Estamos realizando un estudio para comprender las preferencias de los pacientes para los tratamientos para el linfoma. Si está interesado/a y cumple los requisitos para participar, completará una encuesta online

GP0991C General Pustular Psoriasis in the US

At Global Patients we are looking for General Pustular Psoriasis patients in the US to complete a 30min homework and a 60min interview. This survey is aimed to help us to learn more about Generalized Pustular Psoriasis (GPP) from a patient’s perspective. We are interested in the whole journey you have been on with this disease so far. The overall goal of this survey is to learn about the disease

GP0883B Smouldering Multiple Myeloma in US

Evidera, a healthcare research consultancy organization, invites you to participate in a telephone/online interview on your experience with high-risk smoldering multiple myeloma (and multiple myeloma, where applicable). As part of this interview, you will be asked to complete a few forms online via a link that will be emailed to you. The interview will take about 60 minutes to complete. To thank you for your time, we will pay you

GP0963C – Advanced or Metastatic NSCLC Patients with EGFR mutation in the US

We currently have a study in the US to learn more about the experiences of patients with Advanced or Metastatic Lung Cancer (NSCLC). The study will consist of one 45min web-assisted interview. We appreciate the time that patients invest in them, for this reason we offer an incentive of 100USD as a token of appreciation paid via electronic gift card. If you need more information or are interested, please do

GP0757C CLL patients in Aus and in the US

At Global Patients, we are conducting a new study and would really value your opinion. The purpose of the research is to account the experiences of people diagnosed with Chronic Lymphocytic Leukaemia (CLL) in Australia and in the US. The study will take the form of a 45-min audio recording interview, where materials will also be shared on screen to stimulate discussion. As a token of appreciation for their time,

GP0548D cTTP and related conditions in the US

Global Patients is working on a study conducted in the US by IQVIA, a healthcare research firm on behalf of Takeda, aiming to better understand the factors patients take into consideration when deciding the setting where to receive an infusion treatment. To assess this, the study team is inviting different conditions patients to complete a one-time, online survey exploring patient’s preferences for receiving an infusion treatment in different settings. The team is

GP0783D BP patients and caregivers in Spain

Hi all! We have launched the following study in Spain. Please see specifications below: Oportunidad de investigación de mercado para personas que viven con el penfigoide ampolloso (PA): IQVIA, en nombre de una empresa farmacéutica promotora, tiene previsto realizar una entrevista con los pacientes a los que se les haya diagnosticado PA para comprender mejor la experiencia del paciente de esta afección. Los participantes aptos recibirán un vale de regalo

GP0962D Caregivers of XLH patients

At Global Patients we are looking for caregivers of pediatric patients with XLH as well as adult XLH patients to take part on a 60-minute telephone interview. We are looking to better understand the experiences of people living with this condition. This research is in the US. The study does not include any medication in-take. Eligible caregivers/patients would receive 200 USD or 150USD per participant in case of a dyad-interview

GP0831D Rybelsus patients in the UK

At Global Patients we are launching a new study for Type-2 diabetes patients taking Rybelsus in the UK. The purpose of the research is to understand the experiences patients have had whilst taking Rybelsus. Participants will conduct a 15min pre-task from home through an online platform.
In appreciation for your time and insight, you will receive a 60GBP incentive. If you are interested in this study, please contact rebeca@global-patients.com

GP0363C Myasthenia Gravis UK

If you have Myasthenia Gravis you may be eligible to take part in our paid online survey. If you have a friend/relative who has Myasthenia Gravis, please share this advertisement with them, as they could be eligible to take part in our paid survey.

GP0084E – Migraine Patients in the US and UK

We currently have a study in the US and UK to learn more about the experiences of patients with Migraines. The study will consist of a 60 minute-long phone interview. We appreciate the time that patients invest in them, for this reason we offer an incentive of 100USD/GBP as a token of appreciation paid via electronic gift card. If you are interested or know anyone who would be, please do

GP0646C Multiple Myeloma in the UK

We are currently working on a project involving Multiple Myeloma. The purpose of this study is to understand the feelings, perception and experience of multiple myeloma patients. We are currently looking for Multiple Myeloma patients over 18 years old to participate in a 20-min online survey.

GP0999A AML in US and Canada

A research study is underway to develop and refine an electronic diary for adultswho have AML.We are looking for adults (ages 18 and over) diagnosed with relapsedrefractory AML to participate in a 90-minute interview.Interviews will be completed by telephone or videoconference and can bescheduled at your convenience.You will receive up to US$230.00 (or equivalent in local currency) forconfirmation of diagnosis and your participation in the interview.This is not a medication-related

GP1089A Sjogren’s Syndrome in the US

At Global Patients, we have a new study where we want to gather feedback on an app concept created for Sjogren syndrome patients. With your participation, we aim to test the main functionalities of the app to create the patient friendly user interface. The research will take the form of a 60-minute remote user testing session using webcam video and screen sharing. In appreciation for their time, each participant will

GP0758C Ankylosing Spondylitis

At Global Patients we are looking for adults in the US who suffer from Ankylosing Spondylitis to participate in a 45min web-assisted telephone interview.
All participants will receive a 135USD incentive in exchange for their time.
To learn more, please contact miriam@global-patients.com

GP0885D mBC patients treated with Fulvestrant in the US

We are currently recruiting adults with ER+/ HER2- metastatic breast cancer to take part in a paid research interview study. What is the research about? To help us learn more about what it is like to live with mBC, on your daily life To understand your experience with treatment for metastatic breast cancer Why do we need you? Your participation will contribute to a better understanding of metastatic breast cancer

GP0877C Melanoma in the UK

At Global Patients we are looking for people with Melanoma in the UK to take part in one of our studies. It consists of a 45-minute web-assisted telephone interview.
In appreciation of your time, each participant will receive an economic compensation upon completion of the study.
If you or someone you know meets the criteria and would like to participate, please feel free to contact leyre@global-patients.com

GP0888A Acute Myleoid Leukaemia (AML) in the UK

We are helping to recruit participants for research being conducted by Real Sky.This research is sponsored by a pharmaceutical company.The purpose of the research is to learn more about the experiences of patients and caregivers of patients with Acute Myeloid Leukaemia (AML). It is not to discuss any particular medication.The research will consist of a telephone or online interview (60 min length) to share your insights and reflections about treatments

GP0328D Becker Muscular Dystrophy in the US

Clarivate (a research consultancy) is looking for adults aged 18-55 and caregivers of 12–17-year-old adolescents in the US who are living with Becker muscular dystrophy (Becker) to take part in two 45-minute interviews.

GP0820D AATD patients with Pi-ZZ genotype

IQVIATM (www.iqvia.com), a healthcare research firm, is currently conducting a research project with individuals (12 years old and older) who have been diagnosed with Alpha-1 Antitrypsin Deficiency with Liver Disease (AATD-LD) by their physician. The research will involve participating in a telephone interview lasting 60-75 minutes.  In appreciation of your time, we are offering a $150 award. The research will focus on understanding patients’ experiences with AATD-LD, specifically, the signs,

GP0838B MM patients on DRd or VRg agents in the US

Global Patients is working with Evidera, a scientific research company, on behalf of a pharmaceutical company. We are conducting a study in people with multiple myeloma to understand their perspective of and preferences for multiple myeloma treatments. The study does not involve administration or testing of any treatments; we are only interested in opinions. We will not share any of your contact information without your permission. Collaboration is entirely voluntary,

GP0737B PLD patients in USA and UK

At Global Patients we are launching a new study for adults with moderate or severe polycystic liver disease (PLD) in the US and the UK. The research will take the form of up to 2 online surveys. In appreciation of their time, each participant will receive up to 110USD/95GBP upon completion of the study.If you or someone you know meets these criteria and would like to participate, please feel free

GP0497B Geographic Atrophy study in Canada and Australia

Global Patients is working with Modus Outcomes, a scientific research company, on a study about people’s experiences with geographic atrophy (GA), also known as advanced dry age-related macular degeneration (AMD). We are looking for people aged 60 and older living with GA/advanced dry age-related AMD and their main caregiver in Canada and Australia . Patients and caregivers in this study will each participate in a separate 30-45min electronic or telephone survey. No medical treatment will be provided as part of this study. As compensation for your time, each of you will

GP0741D Myasthenia gravis, HDFN, and WAIHA patients in the UK

Global Patients is running a study on behalf of IQVIA, a company that conducts market research for authorities, organizations or pharmaceutical companies, among people with Generalized Myasthenia gravis (gMG), Warm antibody autoimmune hemolytic anemia (wAIHA), and Hemolytic disease of the fetus and new-born (HDFN). We would like to understand what it is like to live with these conditions, and your experience with the care you receive. The study will involve

GP0820C Breast cancer TDIs in the US

We currently have a study in the US with women who have had nonmetastatic breast cancer.
The study will consist of a 90-minute-long interview. We appreciate the time participants invest in our interviews and that’s why we offer an incentive of 200 USD as a token of appreciation.
If you are interested or know anyone who would be, please do not hesitate to contact at judit@global-patients.com

GP0649B CLL and SLL study in the US

Have you been diagnosed with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)? Have you had at least 2 previous rounds of treatment for your CLL or SLL? Do you know the names of your current and previous medications for CLL or SLL? Or are you willing and able to obtain this information from your treating physician? Are you an adult of legal age? If so, you may be

GP0610B Prurigo Nodularis in the US

At Global Patients we have launched a new study to learn more about people living with Prurigo Nodularis.

GP0566D Ankylosing Spondylitis study in the US

At Global Patients we are looking for adults aged ≥18 years with ankylosing spondylitis (AS) in the United States (US) to take part in a 60-minute telephone web-assisted interview. The purpose of the interview is to understand how individuals with AS feel about their condition and what they would consider to be a successful treatment. We will also have a look at a questionnaire to see whether it would be

GP0909C MDS patients and caregivers in the UK

You are invited to take part in a research study by Cerner Enviza and Global Perspectives, independent, third party research organizations, in collaboration with the MDS Foundation and the MDS Alliance, who are conducting this research on behalf of the study sponsor, a pharmaceutical company. The purpose of this study is to learn more about the experiences of people with Myelodysplastic Syndromes (MDS). We would like to understand how people

GP0399D TBI patients and caregivers in the US

IQVIATM (www.iqvia.com) is currently conducting a research study with patients who have a history of traumatic brain injury (TBI) and their caregivers.  The study will involve participating in 2 telephone interviews, each lasting 60 minutes. In appreciation of your time, we are offering a $220 ($110 per interview) honorarium at the completion of both interviews. You may be paid an additional $50 if a confirmation of diagnosis is needed. The

GP0893D OVARIAN CANCER IN THE UK

At Global Patients we would like to invite you to make your views heard as to the real-world burden and impact of ovarian, peritoneal or fallopian tube cancer. The research hopes to identify areas for improvement in supporting the lives of patients and treating oncologists, surgeons and nurses perspectives. By taking part in the survey, your views, alongside those of other patients living with ovarian, peritoneal or fallopian tube cancer

GP0013E SCLC in the US

At Global Patients we are currently working on a project involving Small Cell Lung Cancer sufferers in the US.

GP0656D CICU caregivers and patients in the US

IQVIATM (www.iqvia.com), a healthcare research firm, is currently conducting a research project with patients who have a history of chronic inducible cold urticaria and/or their caregivers. The research will involve participating in a telephone interview lasting up to 90 minutes. In appreciation of your time, we are offering an honorarium of $185 for each interview. The interview will focus on the understanding of the patient’s experience with chronic inducible cold

GP0511D Melanoma in the US

Global Patients is working with IQVIATM (www.iqvia.com), a healthcare research firm, conducting a research project with patients 18 years of age or older, who have been diagnosed with advanced or metastatic melanoma by their physician. The research will involve participating in two telephone interviews. Each of these interviews will last for approximately 60 minutes. In appreciation of your time, we are offering an electronic gift card voucher of $200. The

GP0299D HFpEF in US

At Global Patients we are running a study on behalf of Clarivate. We are looking for adults in the US who are living with heart failure with preserved ejection fraction (HFpEF) and have a Body Mass Index (BMI) greater than 30.0 to take part in a 90-minute interview. The purpose of the interview is to explore your experience of living with HFpEF and what you would consider to be a

GP0509D Type 2 Diabetes + Peripheral Artery Disease patients in US

Clarivate (a research consultancy) are looking for adults in the US who have been diagnosed with all of the following: Type 2 Diabetes (T2DM) AND Peripheral Arterial Disease (PAD) AND “Intermittent claudication,” which means pain in your legs when you’re walking or exercising, which goes away when you rest. If you meet these criteria, Clarivate would like to invite you to take part in one 45-minute interview. The purpose of

GP0235D ALS patients in the US

At Global Patients we are looking for adults in the US who are living with amyotrophic lateral sclerosis (ALS) to take part in a 60-minute interview.

GP0576D HCC study with patients in US

We are looking for adults with Hepatocellular Carcinoma (HCC) in the US to take part in a single 60-minute, online interview. The purpose of the interview is to understand how individuals with HCC experience their condition and their perspectives on treatments. Participation is entirely voluntary, and your personal information will be kept confidential. You will be compensated $185 to thank you for your time. If you are interested in participating

GP0524D Metastatic Pancreatic Cancer in US

Global Patients along with IQVIATM, a worldwide healthcare consulting firm, is currently conducting a research study, to better understand the experience of patients living with metastatic pancreatic cancer. We would like to invite you to participate in this study, which includes a 60-minute semi-structured interview with one of our senior healthcare researchers. The interview will focus on your experience with metastatic pancreatic cancer. We are interested in learning about the

GP0381D ALL patients in US

Global Patients is collaborating on a research study to better understand and assess the experience of patients with acute lymphoblastic leukemia (ALL). The research study is being conducted with IQVIATM, a healthcare research firm (www.iqvia.com), and a pharmaceutical company that is working on developing therapies for patients with ALL. We are seeking patients with ALL who: are age 55 and older are age 40-55 who have comorbidities that make them

GP0548D PTTc y otras enfermedades crónicas en España

Este estudio realizado por IQVIA, una empresa de investigación en salud, en representación de Takeda, tiene como objetivo entender mejor qué tipo de factores tienen en cuenta los pacientes a la hora de escoger el entorno en el que recibirán un tratamiento de infusión. Para evaluarlo, el equipo del estudio invita a los pacientes a completar una única encuesta en internet que analiza las preferencias del paciente cuando recibe un

GP0548D cTTP in the US

A study conducted by IQVIA, a healthcare research firm on behalf of Takeda, is aiming to better understand the factors patients take into consideration when deciding the setting where to receive an infusion treatment. We are currently searching for cTTP (Congenital thrombotic thrombocytopenic purpura) patients in the US who currently receive infusion treatments into a vein for a 40min online survey. To assess this, the study team is inviting patients to

GP0702D mHSPC & mCRPC patients in the US

Global Patients is collaborating on a research study with IQVIA™, a worldwide healthcare consulting firm, and a pharmaceutical company. The aim is to explore the symptoms of prostate cancer and how they have impacted the quality of life of patients and get feedback on a questionnaire designed to assess symptoms. We are seeking patients who have been diagnosed with either metastatic hormone sensitive (mHSPC) or metastatic castration resistant prostate cancer

GP0207B Cardiovascular conditions UK

At Global Patients we have launched a study to learn more about cardiovascular patients in the UK.
It would consist of a 60-90minute web-assisted interview and participants would receive 120GBP upon completion. There is no medication intake related to the study, we are only interested in opinions.
If you wish to learn more, please contact us at miriam@global-patients.com

GP0666D Recurrent uUTIs patients in the US

We are recruiting females, ages 12-70, with recurrent uncomplicated urinary tract infections (UTIs) in the United States to participate in an interview as part of a research study. Participation in this study includes a single, 60-minute interview by telephone or videoconference with the option of a webcam. All study participants will receive $160 in exchange for their time. Interviews will take place in mid-2022. If you are interested in participating

GP0441D RSV Caregivers

We are currently launching a new study, where we want to learn more about the experiences of caregivers of children who have been diagnosed with RSV. The research will take the form of a 90 min web assisted interview. In appreciation of your time, each participant will receive 235 USD upon completion of the study. If you or someone you know meets these criteria and would like to participate, please

GP0052E DLBCL Patients in US

We currently have a study for adults in the US, where we would like to learn more about the experiences of patients with Relapsed/Refractory Diffuse large B-cell Lymphoma (R/R DLBCL). The study will consist of a 60’ minute-long telephone interview. We appreciate the time that patients invest in them, for this reason we offer an incentive of 150 USD as a token of appreciation. If you need more information or

GP0904C Cervical Cancer Patients

At Global Patients we have launched a study concerning Cervical Cancer patients in the US. It would consist of a 60-minute web assisted interview and participants will be rewarded with 125USD in appreciation for their time upon completion of the study. By taking part in the survey your views, alongside those of other patients living with cervical cancer will be heard and help generate scientific evidence. Your participation is entirely

GP0525D MM patients treated with BLENREP in the US

We would like to invite you to take part in a new study for adults with multiple myeloma who have taken the medication, BLENREP. This research will explore your experience with Multiple Myeloma and BLENREP treatment. Your participation in this study will help patients and doctors know what to expect from the treatment. It may also help other patients with multiple myeloma treated with BLENREP in the future. The study

GP0301D mHSPC & nmCRPC patients study in the US

Global Patients is collaborating on a research study to better understand the experience of patients with prostate cancer who have received an androgen receptor inhibitor (ARI) as a form of treatment. The research study is being conducted with IQVIATM, a healthcare research firm (www.iqvia.com), and a pharmaceutical company that is working on developing therapies for patients with prostate cancer.We are seeking adult patients who have been diagnosed with prostate cancer,

GP0261D Caregivers of mild to moderate dementia with apathy US

Hi everyone! We are conducting a study with caregivers of patients with dementia-related apathy in the United States. The study consists of a 60-minute phone interview and a 90 minute follow up interview. To show our appreciation for your time, you will be compensated with $125 for the first interview and $175 for the second interview , plus $25 for sending the required confirmation of diagnosis.If you would like to

JOIN OUR GLOBAL PATIENTS

Are you interested in taking part in scientific studies?

If so, click here and we will ask you a few questions to know you better and let you know about the studies that might suit you.

If you have further questions or if you already are a member of Global Patients and you no longer want to receive more news about our studies, please contact us at

contact@global-patients.com